Association of genetic variants in CYP2C19 and adverse clinical outcomes after treatment with clopidogrel: An updated meta-analysis

被引：17
|
作者：
Liu, Yan Ping [3 ]
Hao, Pan Pan [1 ,2 ]
Zhang, Ming Xiang [1 ,2 ]
Zhang, Cheng [1 ,2 ]
Gao, Fei [1 ,2 ]
Zhang, Yun [1 ,2 ]
Chen, Yu Guo [1 ,2 ]
机构：
[1] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250012, Peoples R China
[2] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan 250012, Peoples R China
[3] Shandong Univ, Sch Med, Inst Expt Nucl Med, Jinan 250012, Peoples R China
来源：
THROMBOSIS RESEARCH | 2011年 / 128卷 / 06期
关键词：
PERCUTANEOUS CORONARY INTERVENTION; OF-FUNCTION POLYMORPHISM; STENT THROMBOSIS; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; TREATED PATIENTS; RISK; GENOTYPE; CYP2C19-ASTERISK-2; ACTIVATION;
D O I：
10.1016/j.thromres.2011.07.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：593 / 594
页数：2
相关论文
共 50 条
  • [1] CYP2C19 Genetic Variants and Clinical Outcomes With Clopidogrel: A Collaborative Meta-Analysis
    Mega, Jessica L.
    Simon, Tabassome
    Anderson, Jeffrey L.
    Bliden, Kevin
    Collet, Jean-Phillippe
    Danchin, Nicolas
    Giusti, Betti
    Gurbel, Paul
    Horne, Benjamin D.
    Kastrati, Adnan
    Montalescot, Gilles
    Neumann, Franz-Josef
    Shen, Lei
    Sibbing, Dirk
    Steg, P. Gabriel
    Trenk, Dietmar
    Wiviott, Stephen D.
    Sabatine, Marc S.
    CIRCULATION, 2009, 120 (18) : S598 - S599
  • [2] The association of CYP2C19 LoF alleles with adverse clinical outcomes in stroke patients taking clopidogrel: An updated meta-analysis
    Biswas, Mohitosh
    Hossain, Md. Shahadat
    Rupok, Tahsin Ahmed
    Hossain, Md. Sabbir
    Sukasem, Chonlaphat
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (04):
  • [3] CYP2C19 Genotype and Outcomes of Clopidogrel Treatment
    Siasos, Gerasimos
    Tousoulis, Dimitris
    Stefanadis, Christodoulos
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (05): : 481 - 482
  • [4] The effect of CYP2C19*17 on platelet response and clinical outcomes in patients taking clopidogrel: a meta-analysis
    Fang, H.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 479 - 479
  • [5] CYP2C19 Genotype and Outcomes of Clopidogrel Treatment REPLY
    Pare, Guillaume
    Mehta, Shamir R.
    Eikelboom, John W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (05): : 482 - 482
  • [6] Effects of CYP2C19 Genotype on Outcomes of Clopidogrel Treatment
    Pare, Guillaume
    Mehta, Shamir R.
    Yusuf, Salim
    Anand, Sonia S.
    Connolly, Stuart J.
    Hirsh, Jack
    Simonsen, Katy
    Bhatt, Deepak L.
    Fox, Keith A. A.
    Eikelboom, John W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18): : 1704 - 1714
  • [7] Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI A Meta-analysis
    Mega, Jessica L.
    Simon, Tabassome
    Collet, Jean-Philippe
    Anderson, Jeffrey L.
    Antman, Elliott M.
    Bliden, Kevin
    Cannon, Christopher P.
    Danchin, Nicolas
    Giusti, Betti
    Gurbel, Paul
    Horne, Benjamin D.
    Hulot, Jean-Sebastian
    Kastrati, Adnan
    Montalescot, Gilles
    Neumann, Franz-Josef
    Shen, Lei
    Sibbing, Dirk
    Steg, P. Gabriel
    Trenk, Dietmar
    Wiviott, Stephen D.
    Sabatine, Marc S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (16): : 1821 - 1830
  • [8] CYP2C19 genotype and adverse cardiovascular outcomes after stent implantation in clopidogrel-treated Asian populations: A systematic review and meta-analysis
    Xi, Ziwei
    Fang, Fang
    Wang, Jiayang
    AlHelal, Jumana
    Zhou, Yujie
    Liu, Wei
    PLATELETS, 2019, 30 (02) : 229 - 240
  • [9] Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis
    Bauer, Tim
    Bouman, Heleen J.
    van Werkum, Jochem W.
    Ford, Neville F.
    ten Berg, Jurrien M.
    Taubert, Dirk
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
  • [10] ANALYSIS OF TICAGRELOR AND PRASUGREL CORRELATION WITH CYP2C19 GENETIC VARIANTS AS ALTERNATIVE DRUGS FOR CLOPIDOGREL
    Seo, B.
    Lee, S.
    Lee, I.
    Kim, S.
    Chiang, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S22 - S22
12345